Development of a mobile phone-based intervention to improve adherence to secondary prevention of coronary heart disease in China

被引：13

作者：

Chen S. ^{[1
]}

Gong E. ^{[1
]}

Kazi D.S. ^{[2
,3
]}

Gates A.B. ^{[4
]}

Karaye K.M. ^{[5
]}

Girerd N. ^{[6
,7
]}

Bai R. ^{[8
,9
]}

AlHabib K.F. ^{[10
]}

Li C. ^{[1
]}

Sun K. ^{[11
]}

Hong L. ^{[11
]}

Fu H. ^{[12
]}

Peng W. ^{[13
]}

Liu X. ^{[14
]}

Chen L. ^{[14
]}

Schwalm J.-D. ^{[15
]}

Yan L.L. ^{[1
,15
]}

机构：

[1] Global Health Research Center, Duke Kunshan University, Kunshan

[2] Division of Medicine (Cardiology), University of California San Francisco, San Francisco, CA

[3] Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA

[4] Exercise Works Ltd, Derby

[5] Department of Medicine, Bayero University/Aminu Kano Teaching Hospital, Kano

[6] INSERM, Centre d’ Investigations Cliniques 9501, Université de Lorraine, CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux, Nancy

[7] INI-CRCT (Cardiovascular and Renal Clinical Trialists) FCRIN Network, Nancy

[8] National Clinical Research Center for Cardiovascular Diseases, Beijing

[9] Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing

[10] College of Medicine, King Saud University, Riyadh

[11] Degroote School of Medicine, McMaster University, Hamilton, ON

[12] School of Public Health, Fudan University, Shanghai

[13] Department of Cardiology, Hainan Nongken General Hospital, Haikou

[14] McMaster University/Hamilton Health Sciences, Population Health Research Institute, Hamilton, ON

[15] Duke Global Health Institute, Duke University, Durham, NC

来源：

Journal of Medical Engineering and Technology | 2016年 / 40卷 / 7-8期

关键词：

Heart disease; lifestyle; medication adherence; mobile health; secondary prevention;

D O I：

10.1080/03091902.2016.1213904

中图分类号：

学科分类号：

摘要：

Coronary heart disease (CHD) is a major disease burden globally and in China, but secondary prevention among CHD patients remains insufficient. Mobile health (mHealth) technology holds promise for improving secondary prevention but few previous studies included both provider-facing and patient-directed measures. We conducted a physician needs assessment survey (n = 59), physician interviews (n = 6), one focus group and a short cellphone message validation survey (n = 14) in Shanghai and Hainan, China. Based on these results, we developed a multifaceted mHealth intervention that includes: (1) a provider-facing bilingual mobile app guiding prescription of evidence-based medications for secondary prevention and (2) a patient-directed short messaging system automatically sending reminders to patients regarding medication adherence and lifestyle changes (4–5 messages per week for 12 weeks). This combined intervention has the potential to improve secondary prevention of CHD and to be adapted to other countries and healthcare conditions. © 2016 Informa UK Limited, trading as Taylor & Francis Group.

引用

页码：372 / 382

页数：10

共 18 条

[1]

Zhang X.H., Lu Z.L., Liu L., Coronary heart disease in China, Heart, 94, pp. 1126-1131, (2008)

[2]

Jiang G., Wang D., Li W., Et al., Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transition, Rev Panam Salud Publica, 31, pp. 317-324, (2012)

[3]

Gaziano T.A., Opie L.H., Weinstein M.C., Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis, Lancet, 368, pp. 679-686, (2006)

[4]

Perk J., De Backer G., Gohlke H., Et al., European guidelines on cardiovascular disease prevention in clinical practice (version 2012), Eur Heart J, 33, pp. 1635-1701, (2012)

[5]

Guidelines for cardiac rehabilitation and secondary prevention programs, (2013)

[6]

Jones K., Saxon L., Cunningham W., Et al., Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance, BMJ, 347, (2013)

[7]

Liu H., Yu J., Pan C., Et al., Cross-sectional study on the prevalence of metabolic syndrome in patients with coronary heart disease in China, Natl Med J China, 86, pp. 2095-2098, (2006)

[8]

Teo K., Lear S., Islam S., Et al., Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle-and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study, JAMA, 309, pp. 1613-1621, (2013)

[9]

Yusuf S., Islam S., Chow C.K., Et al., Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey, Lancet, 378, pp. 1231-1243, (2011)

[10]

Bi Y., Gao R., Patel A., Et al., Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study, Am Heart J, 157, pp. 509-516, (2009)

← 1 2 →